| abstract |
The invention relates to novel pyrazol pyridine derivatives of formula (I), wherein R1 signifies a radical of formula -O-SO¿2?-R?3, R3¿ represents a radical from the group consisting of optionally substituted C¿1-6?-alkyl, optionally substituted C3-8-cycloalkyl, or optionally substituted phenyl, R?2¿ represents H or optionally substituted C¿1-6-?alkyl-SO2-; in addition to the salts, isomers and hydrates thereof, as stimulators of soluble guanylate cyclase, and to the use thereof as agents for treating cardio-vascular diseases, hypertonia, thromboembolic diseases and ischaemia, sexual dysfunction or inflammations and for treating diseases of the central nervous system |